Cargando…
The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile
BACKGROUND: Cytochrome P450 (CYP) enzyme 2J2, an epoxygenase predominantly expressed in the heart, metabolises arachidonic acid to biologically active eicosanoids. One of the CYP2J2 products, 11, 12-epoxyeicosatrienoic acid, has several vasoprotective effects. The CYP2J2-G-50T-promotor polymorphism...
Autores principales: | Börgel, Jan, Bulut, Daniel, Hanefeld, Christoph, Neubauer, Horst, Mügge, Andreas, Epplen, Jörg T, Holland-Letz, Tim, Spiecker, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626571/ https://www.ncbi.nlm.nih.gov/pubmed/19105833 http://dx.doi.org/10.1186/1471-2261-8-41 |
Ejemplares similares
-
Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of β2-adrenergic receptor polymorphisms
por: Bartels, Nina K, et al.
Publicado: (2007) -
Meta-analysis of the association of the CYP2J2 G-50T polymorphism with coronary artery disease
por: Chen, Jian, et al.
Publicado: (2017) -
The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2
por: Tian, Xiangge, et al.
Publicado: (2021) -
Higher Epoxyeicosatrienoic Acids in Cardiomyocytes-Specific CYP2J2 Transgenic Mice Are Associated with Improved Myocardial Remodeling
por: Aliwarga, Theresa, et al.
Publicado: (2020) -
Role of Cyp2j6 in Brown Adipogenesis
por: Zhao, Ling, et al.
Publicado: (2022)